Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Medline Inc. (MDLN)

Medline director Joseph Baratta to resign from board effective December 31, 2026

Neutral Impact 2 of 5 leadership Written later

Medline Inc. disclosed that director Joseph P. Baratta notified the Board on October 13, 2026 that he will resign, effective December 31, 2026. The company said the decision coincides with his previously announced departure from Blackstone Inc. and is not due to any disagreement over company operations, policies, or practices.

Key points

  • Joseph P. Baratta notified the Board on October 13, 2026 of his decision to resign.
  • Resignation is effective December 31, 2026.
  • Company states there was no disagreement with management related to operations, policies, or practices.
  • Filing was signed by Chief Legal Officer Alex M. Liberman on October 15, 2026.

The filing

CompanyMedline Inc. (MDLN)
Form8-K, current report
Filed with the SECOct 15, 2026, 4:18 PM ET
Accession number0001104659-26-116255

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.